Clinical Trial Update: Myelodysplastic Syndrome--CDA-2 Hematological Improvement National Affirmation Study [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update for Myelodysplastic Syndromes evaluating CDA-2 hematologic improvement in a national study. The status is currently UNKN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• CDA-2

Snippet

Sponsor: Chinese Society of Hematology | Conditions: Myelodysplastic Syndrome (MDS) | Phase 4 | Status: UNKNOWN